Price alert —
Sign in to get a one-time email the moment LNTH crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · LNTH
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.4B | $0.1B | $0.1B | $0.1B | 31.4% | 21.6% |
| 2025-12-31 | $0.4B | $0.1B | $0.1B | $0.1B | 13.3% | 19.0% |
| 2025-09-30 | $0.4B | $0.0B | $0.0B | $0.1B | 7.2% | 11.4% |
| 2025-06-30 | $0.4B | $0.1B | $0.1B | $0.1B | 20.8% | 23.3% |
| 2025-03-31 | $0.4B | $0.1B | $0.1B | $0.1B | 19.6% | 28.6% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare LNTH vs peers
Line LNTH up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with LNTH
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-07 | 1.46 | 1.23 | +18.8% | +2.3% |
| 2026-02-26 | 1.67 | 1.17 | +42.9% | -0.7% |
| 2025-11-06 | 1.27 | 1.27 | +0.2% | -4.9% |
| 2025-08-06 | 1.57 | 1.68 | -6.3% | +5.8% |
| 2025-05-07 | 1.53 | 1.65 | -7.5% | -0.1% |
| 2025-02-26 | 1.59 | 1.54 | +3.0% | -1.9% |
| 2024-11-06 | 1.70 | 1.56 | +9.1% | -3.1% |
| 2024-07-31 | 1.80 | 1.83 | -1.6% | -5.9% |
| 2024-05-02 | 1.69 | 1.54 | +9.5% | -3.4% |
| 2024-02-22 | 1.75 | 1.44 | +21.2% | +1.9% |
| 2023-11-02 | 1.47 | 1.32 | +11.2% | +3.5% |
| 2023-08-03 | 1.54 | 1.31 | +17.4% | +3.6% |
| 2023-05-04 | 1.47 | 1.29 | +13.7% | -0.8% |
| 2023-02-23 | 1.37 | 0.96 | +42.2% | +3.5% |
| 2022-11-03 | 0.99 | 0.83 | +19.3% | +0.9% |
| 2022-08-04 | 0.89 | 0.70 | +26.7% | +10.3% |
| 2022-04-29 | 0.97 | 0.46 | +110.9% | -0.7% |
| 2022-02-24 | 0.25 | 0.17 | +50.0% | +16.1% |
| 2021-11-04 | 0.08 | 0.06 | +26.3% | +5.0% |
| 2021-07-28 | 0.11 | 0.05 | +120.0% | +0.1% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| LNTH ★ | $7B | 25.0 | 16.6 | 4.4 | 18.8 | 5.6 | 60.5% | 1.2% | 76.5% | 6.18% |
| LLY | $1,067B | 42.5 | 26.7 | — | 30.3 | 34.3 | 82.8% | 55.5% | 169.9% | 0.86% |
| UNH | $382B | 31.6 | 18.8 | 0.8 | 17.6 | 3.6 | 19.5% | 0.4% | 61.5% | 5.96% |
| JNJ | $634B | 30.6 | 20.5 | 6.5 | 18.9 | 7.8 | 68.1% | 6.6% | -1.0% | — |
| MRK | $324B | 36.9 | 13.6 | — | 12.4 | 7.1 | 76.7% | 4.9% | — | 4.34% |
| ABBV | $458B | 127.8 | 15.9 | 7.3 | 17.3 | -68.9 | 72.0% | 12.4% | -46.2% | 4.54% |
| PFE | $140B | 18.7 | 8.7 | — | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.85% |
| TMO | $211B | 30.6 | 20.8 | — | 21.5 | 4.1 | 40.9% | 10.5% | 9.4% | 2.93% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 56.66%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 8,183,193 | 12.57% |
| Farallon Capital Management LLC | 5,583,479 | 8.58% |
| Janus Henderson Group PLC | 4,774,841 | 7.33% |
| FMR, LLC | 4,626,453 | 7.11% |
| Vanguard Portfolio Management LLC | 3,174,274 | 4.88% |
| Vanguard Capital Management LLC | 2,914,314 | 4.48% |
| State Street Corporation | 2,429,803 | 3.73% |
| American Century Companies Inc | 1,781,106 | 2.74% |
| Geode Capital Management, LLC | 1,765,952 | 2.71% |
| Morgan Stanley | 1,646,463 | 2.53% |
Insider activity · 90d
9 buys / 0 sells · ratio 9.0 · Finnhub
- Ber Gerard F 27,118 @ $96.67
- Heino Mary Anne F 321,897 @ $96.67
- Morrow Phuong Khanh BUY 7,237
- Maeusli Heinz Christoph BUY 30,014
- Pruden Gary J BUY 6,674
- Baylor-Henry Minnie BUY 14,018
- Ber Gerard BUY 27,499
- EASTLAND JULIA MARIE BUY 8,019
- McHugh Julie BUY 30,099
- Thrall James H BUY 39,881
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-06-03 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-06-03 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-05-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-05-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-05-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-05-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-05-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-05-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-05-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-05-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-05-18 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 10-Q | 2026-05-07 | 10-Q | view · |
| 8-K | 2026-05-07 | 8-K | view · |
| 8-K | 2026-05-01 | 8-K | view · |
| 4 | 2026-04-21 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| DEF 14A | 2026-03-20 | DEF 14A | view · |
| 4 | 2026-03-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-03-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-03-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-03-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-03-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-03-04 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-03-04 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-03-04 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2026-03-04 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 10-K | 2026-02-26 | 10-K | view · |
| 8-K | 2026-02-26 | 8-K | view · |
| 4 | 2025-12-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-11-19 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 8-K | 2025-11-12 | 8-K | view · |
| 10-Q | 2025-11-06 | 10-Q | view · |
| 8-K | 2025-11-06 | 8-K | view · |
| 4 | 2025-09-03 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-08-21 | Insider transaction (Form 4) | view · |
| 4 | 2025-08-21 | Insider transaction (Form 4) | view · |
| 4 | 2025-08-19 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-08-19 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-08-15 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 8-K | 2025-08-11 | 8-K | view · |
| 10-Q | 2025-08-06 | 10-Q | view · |
| 8-K | 2025-08-06 | 8-K | view · |
| 8-K | 2025-07-22 | 8-K | view · |
| 4 | 2025-07-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-06-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-06-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-06-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-06-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-06-09 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-06-04 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-29 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
About LNTH
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; PYLARIFY AI, an medical device software to perform quantitat…
Options picks · LNTH
ITM + OTM ideas from the latest scanLoading…
Congress trades · LNTH
STOCK Act disclosuresLoading…
SEC filings & insiders · LNTH
EDGAR · liveLoading…
Holders · LNTH
Institutions & insider activityLoading…